title: Is it variants in the apolipoprotein l1 gene, or blood pressure control, that predicts progression of nondiabetic hypertensive nephropathy in African Americans?
authors.affiliation: Renal Hypertension Division, University of Pennsylvania, Philadelphia, PA 19104, USA. debbie.cohen@uphs.upenn.edu
authors.forename: Debbie L
authors.initials: DL
authors.lastname: Cohen
authors.forename: Raymond R
authors.initials: RR
authors.lastname: Townsend
mesh_terms: D001741:Black or African American / Q000235:genetics*; D000075944:Apolipoprotein L1; D001053:Apolipoproteins / Q000235:genetics*; D001794:Blood Pressure / Q000235:genetics / Q000502:physiology; D018450:Disease Progression; D014644:Genetic Variation / Q000235:genetics*; D006801:Humans; D006973:Hypertension / Q000235:genetics / Q000503:physiopathology / Q000517:prevention & control*; D006977:Hypertension, Renal / Q000175:diagnosis* / Q000235:genetics / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology; D008075:Lipoproteins, HDL / Q000235:genetics*; D009393:Nephritis / Q000175:diagnosis* / Q000235:genetics / Q000503:physiopathology; D011237:Predictive Value of Tests; D012307:Risk Factors; D044465:White People / Q000235:genetics
chemical_list: C108666:APOL1 protein, human; D000075944:Apolipoprotein L1; D001053:Apolipoproteins; D008075:Lipoproteins, HDL